JPMorgan Chase & Co’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.51K Sell
3,690
-13,941
-79% -$28.4K ﹤0.01% 5488
2025
Q1
$28.7K Buy
17,631
+5,687
+48% +$9.27K ﹤0.01% 5180
2024
Q4
$21.9K Buy
11,944
+190
+2% +$348 ﹤0.01% 5208
2024
Q3
$67.9K Buy
11,754
+458
+4% +$2.65K ﹤0.01% 4880
2024
Q2
$91.3K Buy
11,296
+10,823
+2,288% +$87.5K ﹤0.01% 4638
2024
Q1
$6.57K Sell
473
-652
-58% -$9.05K ﹤0.01% 5394
2023
Q4
$6.89K Sell
1,125
-4,055
-78% -$24.8K ﹤0.01% 5473
2023
Q3
$24.2K Sell
5,180
-246,360
-98% -$1.15M ﹤0.01% 5105
2023
Q2
$1.35M Sell
251,540
-21,299
-8% -$114K ﹤0.01% 3250
2023
Q1
$2.68M Sell
272,839
-243
-0.1% -$2.39K ﹤0.01% 2865
2022
Q4
$5.11M Sell
273,082
-1,775
-0.6% -$33.2K ﹤0.01% 2356
2022
Q3
$5.69M Sell
274,857
-11,431
-4% -$237K ﹤0.01% 2253
2022
Q2
$5.94M Sell
286,288
-447
-0.2% -$9.28K ﹤0.01% 2276
2022
Q1
$12.4M Sell
286,735
-29,755
-9% -$1.28M ﹤0.01% 1872
2021
Q4
$19M Sell
316,490
-25,828
-8% -$1.55M ﹤0.01% 1626
2021
Q3
$29.4M Buy
342,318
+55,897
+20% +$4.8M ﹤0.01% 1322
2021
Q2
$31.9M Buy
286,421
+154,790
+118% +$17.2M ﹤0.01% 1317
2021
Q1
$14.7M Buy
131,631
+40,244
+44% +$4.48M ﹤0.01% 1824
2020
Q4
$9.71M Buy
91,387
+38,991
+74% +$4.14M ﹤0.01% 1951
2020
Q3
$7.11M Buy
52,396
+2,581
+5% +$350K ﹤0.01% 1991
2020
Q2
$16.1M Buy
49,815
+12,723
+34% +$4.11M ﹤0.01% 1385
2020
Q1
$3.31M Buy
37,092
+22,922
+162% +$2.05M ﹤0.01% 2275
2019
Q4
$561K Sell
14,170
-23,452
-62% -$928K ﹤0.01% 3362
2019
Q3
$925K Buy
37,622
+2,254
+6% +$55.4K ﹤0.01% 3098
2019
Q2
$1.24M Buy
35,368
+32,917
+1,343% +$1.15M ﹤0.01% 2937
2019
Q1
$110K Buy
2,451
+73
+3% +$3.28K ﹤0.01% 3975
2018
Q4
$114K Buy
2,378
+231
+11% +$11.1K ﹤0.01% 3994
2018
Q3
$143K Buy
2,147
+744
+53% +$49.6K ﹤0.01% 3990
2018
Q2
$66K Sell
1,403
-340
-20% -$16K ﹤0.01% 4211
2018
Q1
$98K Sell
1,743
-44
-2% -$2.47K ﹤0.01% 3936
2017
Q4
$89K Buy
1,787
+1,513
+552% +$75.4K ﹤0.01% 3946
2017
Q3
$21K Buy
274
+34
+14% +$2.61K ﹤0.01% 3959
2017
Q2
$23K Buy
240
+29
+14% +$2.78K ﹤0.01% 3900
2017
Q1
$16K Buy
211
+3
+1% +$227 ﹤0.01% 4132
2016
Q4
$18K Buy
208
+151
+265% +$13.1K ﹤0.01% 4181
2016
Q3
$6K Sell
57
-535
-90% -$56.3K ﹤0.01% 3901
2016
Q2
$66K Sell
592
-532
-47% -$59.3K ﹤0.01% 3477
2016
Q1
$118K Buy
1,124
+154
+16% +$16.2K ﹤0.01% 3250
2015
Q4
$78K Sell
970
-2,038
-68% -$164K ﹤0.01% 3282
2015
Q3
$209K Buy
3,008
+61
+2% +$4.24K ﹤0.01% 3155
2015
Q2
$289K Buy
2,947
+1,580
+116% +$155K ﹤0.01% 3224
2015
Q1
$134K Buy
1,367
+213
+18% +$20.9K ﹤0.01% 3373
2014
Q4
$127K Hold
1,154
﹤0.01% 3324
2014
Q3
$136K Buy
+1,154
New +$136K ﹤0.01% 3314
2013
Q3
Sell
-3,167
Closed -$121K 3905
2013
Q2
$121K Buy
+3,167
New +$121K ﹤0.01% 3651